You Manage Financial Portfolios Over Time.
Why Not Your Biological One?
Your financial portfolio is not evaluated once and forgotten. It is measured, interpreted, adjusted, and monitored as conditions change. Your biology should be held to the same standard.
Biological Portfolio Management™ is EXOPYR’s physician-directed approach to inflammation care based on biological change over time.
.
Baseline
Where am I?
.
Week 8
Did I respond?
.
Month 6
Where am I going?
.
Month 12
How does my biology behave over time?
One Data Point Is a Snapshot. Change Is the Signal.
Traditional testing shows where a biomarker is today, but a single measurement cannot show direction, establish response, or reveal whether a change is temporary, sustained, or part of a larger biological pattern. Biological Portfolio Management is designed to address that limitation by measuring across multiple biological levels, interpreting change in context, and using physician-directed care to understand how the system responds and evolves over time.
It Starts With an Assessment.
Before you manage a portfolio, you need to understand what you are managing. That is why Biological Portfolio Management begins with the Inflammation Reset™ Assessment, a physician-directed clinical evaluation designed to determine whether the EXOPYR Inflammation Reset is appropriate for you.
The Assessment establishes the clinical context necessary to understand your current inflammatory picture. Rather than assuming that every person should enter the same program, EXOPYR begins by evaluating the individual, reviewing relevant clinical information, and determining the appropriate next step. For qualified clients, that next step is the Inflammation Reset.
First, Establish How Your Biology Responds.
The Inflammation Reset creates the first measurable interval within Biological Portfolio Management. Baseline laboratory testing establishes the starting point, followed by physician-directed care and a structured intervention. Approximately eight weeks later, laboratory testing is repeated under standardized conditions, creating a second biological measurement that can be compared with the first.
With two points instead of one, the clinical question changes. We are no longer asking only where your biomarkers are. We can begin asking the more consequential question: Did my biology respond?
Then, Follow the Direction of Change.
For some clients, establishing that initial response is the objective. For others, eight weeks provides the beginning of a much longer biological picture. Biological Portfolio Management can extend the measurement horizon through six-month and twelve-month physician-directed engagements, allowing biological changes to be evaluated longitudinally rather than as isolated events.
As the engagement deepens, so does the question being asked. The Inflammation Reset asks, “Did my biology respond?” Six-month management asks, “Where is my biology going?” Twelve-month management asks, “How does my biology behave over time?” The progression moves from establishing an initial response to understanding direction, patterns, and biological behavior across a longer period.
Inflammation Is a System.
Inflammation does not operate independently of the rest of your biology. EXOPYR evaluates it through a coordinated framework spanning four biological levels: Systemic, Genetic, Cellular, and Repair. This allows biological change to be interpreted as part of an interconnected system rather than reducing inflammation to a single laboratory value or isolated point in time.
That systems-based approach is the clinical foundation of Biological Portfolio Management.
You Wouldn’t Manage Wealth From One Snapshot.
Don’t Manage Your Biology That Way.
You already understand the logic of disciplined measurement: establish the current position, measure change, interpret the signal, make informed decisions, and continue monitoring when circumstances warrant it. Biological Portfolio Management brings that same longitudinal discipline to physician-directed inflammation care.
The process does not begin by assuming which program you need. It begins by determining whether EXOPYR’s approach is appropriate for you.
Start With the Inflammation Reset Assessment.
The Inflammation Reset Assessment is the entry point into the EXOPYR clinical process. Your case is evaluated before a recommendation is made regarding the Inflammation Reset or a longer Biological Portfolio Management engagement. The objective is to establish clinical context first, determine the appropriate starting point, and only then decide how deeply your biology should be measured and managed over time.
EXOPYR®, Extinguish Inflammation®, Inflammation Reset™, and the EXOPYR flame logo are trademarks of EXOPYR Holdings, LLC. © 2025–2026 EXOPYR Holdings, LLC. All rights reserved.
These statements have not been evaluated by the FDA. This protocol is not intended to diagnose, treat, cure, or prevent any disease.